STOCKHOSPITAL & MEDICAL SERVICE PLANSUpdated 2026-04-19
Here’s whether Oscar Health, Inc. (OSCR) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Caution.
🟡
Caution
Positives: above the 50-day MA (medium-term momentum positive); strong 1-year return of +27.9%. Concerns: trading below the 200-day MA (long-term downtrend); RSI 89 — overbought, elevated pullback risk. Currently 33.7% off its 52-week high. Score: -1/7.
OSCR is trading below its 200-day MA ($15.86) — a key warning sign the longer-term trend is under pressure. With an RSI of 88.8, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +27.9% compares to +35.1% for SPY (trailed the market by 7.2%). The current 33.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $12,785 today
vs. S&P 500 (SPY) — same period trailed market by 7.2%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($15.86)
✓Above 50-day MA ($13.33)
!RSI(14) neutral zone (30–70) — currently 88.8
✓Positive return (+27.9%)
!Within 10% of period high (−33.7%)
Period Range $15.79
$10.69$23.80
RSI (14) 88.8
0 · OversoldOverbought · 100
Key Metrics
Price$15.79
Period Return+27.9%
Period High$23.80
Period Low$10.69
Drawdown−33.7%
MA-50$13.33
MA-200$15.86
RSI (14)88.8
Avg Volume (30d)6.6M
vs. SPYtrailed by 7.2%
Return Rank#499 of 996
Trend Signals
Price is below the 200-day moving average ($15.86)